Trials / Completed
CompletedNCT00774761
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease
A Randomized, Multiple-Dose,Double-Blind,Crossover Trial to Assess the Systemic Exposure of Fluticasone Propionate (FP)/Formoterol Fumarate (FF) Fixed-Dose Combination in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the systemic exposure and pharmacodynamics of two doses of nebulized fluticasone/formoterol combination as compared to the monocomponents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluticasone propionate/formoterol fumarate | inhalation suspension |
| DRUG | fluticasone propionate | inhalation suspension |
| DRUG | formoterol fumarate | inhalation solution |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2008-10-17
- Last updated
- 2013-05-20
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00774761. Inclusion in this directory is not an endorsement.